Development of an mHealth Tool (ANíMATE) to Assess Self-management, Self-care and Adherence in People With Obesity
NCT05236881 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2025-11-18
Summary
This trial main purpose is to develop and test an mHealth app aimed at improving self-management, self-care and adherence of people with obesity.
The study population are type I or II obese people, aged more than 18 years old, with or without comorbidities, who have a smartphone or tablet compatible with the app (Android version 9.0 or higher) and access to a scale for regular weight monitoring.
Control group will follow standard care protocol and patients in the intervention group will also be provided with the app. Follow-up will be done for 16 weeks. Both groups will attend 3 face-to-face visits (baseline, 2 and 4 months).
Conditions
Interventions
- DEVICE
-
ANíMATE mobile application
mHealth tool ANíMATE (Adherence, Nutrition, PhysIcal Activity, Motivation, medicAtion, Technology and Empowerment) allows the recording of data related to diet and exercise and feedback on behavior through an intelligent data analysis system.
Sponsors & Collaborators
-
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-20
- Primary Completion
- 2024-11-13
- Completion
- 2025-01-31
Countries
- Spain
Study Locations
More Related Trials
-
A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
NCT06525935 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TG103 Injection in Overweight or Obesity
NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2
-
3mg Liraglutide for Overweight or Obesity
NCT03885297 ·Status: COMPLETED
-
A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
NCT07281937 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of TG103 Injection in Non-diabetic Overweight or Obesity
NCT05997576 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Ingested, Space Occupying Hydrogel Capsules for Simple Obesity Treatment
NCT06530017 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Litramine on Fat Excretion
NCT01590667 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers
NCT03685656 ·Status: COMPLETED ·Phase: NA
-
This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity
NCT06857617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
NCT05093634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions
NCT06867718 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of a Novel Precision Medicine Approach For Obesity
NCT06814938 ·Status: RECRUITING ·Phase: PHASE4
-
Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight
NCT07110766 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus
NCT05814107 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity
NCT04478708 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
NCT05110846 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
NCT05869903 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Study of [14C] GZR18
NCT07119450 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3537031 in Overweight, Obese, and Healthy Participants
NCT06606106 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus
NCT07192263 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study of MET233 in Individuals With Obesity or Overweight
NCT07022977 ·Status: COMPLETED ·Phase: PHASE1
-
PathMate2: The Impact of Health Information System Services on the Effects of Therapy in Overweight Teenagers
NCT03270423 ·Status: COMPLETED ·Phase: NA
-
A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or Obesity
NCT06352437 ·Status: COMPLETED ·Phase: PHASE1
-
VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt
NCT00299325 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
NCT07311850 ·Status: RECRUITING ·Phase: PHASE3